198例小儿支原体肺炎的临床分析

目的:探讨小儿支原体肺炎的临床特点及α-干扰素、阿奇霉素联合应用的治疗作用。方法:对198例小儿支原体肺炎患儿的临床特点以及联合使用α-干扰素与阿奇霉素治疗效果进行数据统计分析。结果:患儿年龄以1～3岁的婴幼儿为主(80.8%),发热(98.5%),不同程度咳嗽(100%),其中以刺激性干咳为主(49.5%),多数肺部可闻及杂音,外周血白细胞大多正常(61.1%),MP-IgM阳性(100%),出现肺外并发症(36.9%),胸片显示均有支气管肺炎型改变。所有患者使用α-干扰素与阿奇霉素联合治疗后,疗效明显。结论:小儿支原体肺炎好发于1～3岁婴幼儿,其临床表现及辅助检查不易与其他肺炎相鉴别,故MP-IgM检查尤为重要,α-干扰素与阿奇霉素联合应用疗效明显,值得临床治疗广泛使用。

The clinical analysis of mycoplasma pneumonia(MPP) in 198 cases

Objective To explore the clinical features of Mycoplasma pneumoniae and α-interferon,combined application of azithromycin treatment.Method 198 cases of mycoplasma pneumonia in children with clinical features,and α-interferon combination treatment with azithromycin statistical analysis of data.Results Children aged 1 to 3-year-old infants based(80.8%),fever(98.5%),varying degrees of cough(100%),which mainly irritating dry cough(49.5%),the majority of the lungs could be heard and noise,most of the normal peripheral blood leukocytes(61.1%) MP-IgM positive(100%),pulmonary complication occurs(36.9%),chest X-ray showed bronchial pneumonia-type changes.All patients with α-interferon combination therapy with azithromycin had the curative effect.Conclusion Mycoplasma pneumonia occurs in 1 to 3-year-old infants,the clinical manifestations and laboratory examinations and other easily differentiated from pneumonia,it is particularly important to check the MP-IgM,α-interferon in combination with azithromycin efficacy,it is widely used in clinical treatment.